Pharmaceutics International, Inc (Pii) appoints Sridhar Krishnan as Senior Vice President, Operations & Strategic Initiatives - March 2020
HUNT VALLEY, MD (March 23, 2020) – Pharmaceutics International, Inc. (Pii), a leading Contract Development and Manufacturing Organization (CDMO) using Pharmaceutics Know-How™ to support the development and cGMP manufacture of a wide range of dosage forms, from sterile and non-sterile liquids to oral solid and semi-solid drug products, today announced the appointment of Sridhar Krishnan as Senior Vice President, Operations & Strategic Initiatives.
Mr. Krishnan will report to Dr. Kurt R. Nielsen, the company’s President and CEO. As Senior Vice President of Operations & Strategic Initiatives, Mr. Krishnan will have direct responsibility for all aspects of operations, which includes oral and topical drug delivery, sterile and non-sterile manufacturing operations, supply chain, IT, technical operations, engineering and operational excellence. In addition, Mr. Krishnan will work closely with Board of Directors, Executive Leadership Team and Sales & Marketing to drive strategic growth initiatives for Pii.
Mr. Krishnan has over 25 years of experience in global supply chain operations & quality, customer fulfillment, global procurement and general management roles within the pharmaceutical, biologics, contract manufacturing (CDMO), contract research (CRO) and medical device industries. His most recent position was with Frontage Laboratories, where he served as Senior Vice President of Global Operations. He has also worked for Catalent Pharma Solutions & GE Healthcare wherein Mr. Krishnan held several global leadership positions in operations, supply chain, procurement and operational excellence. Throughout his career, Mr. Krishnan’s success has been driven by building high performing leadership teams and driving sustainable business transformations across the network.
Mr. Krishnan holds a bachelor’s degree in mechanical engineering from Bangalore University. He is also a certified lean six sigma master black belt from GE.
“We are grateful to have Mr. Krishnan join our team of experts and proven leaders at Pharmaceutics International Inc. He brings an impressive depth and breadth of technical, managerial and leadership experiences to Pii, our customers and the patients we ultimately serve with our Pharmaceutics Know-How™,” said Dr. Kurt Nielsen, Pii’s President and CEO.
Pii is a privately held CDMO providing dosage form development and cGMP manufacturing services to the global pharmaceutical industry. Headquartered in Hunt Valley, Maryland USA, Pii’s services include pre-formulation studies, formulation development, and clinical and commercial cGMP manufacturing of parenterals, liquid solutions and oral solids, including soft gels, tablets and capsules. In addition, the Company offers containment suites to handle potent drugs and Schedules I-V controlled substances.
For more information, please visit pharm-int.com.